Progression and metastasis of lung cancer

Metastasis in lung cancer is a multifaceted process. In this review, we will dissect the process in several isolated steps such as angiogenesis, hypoxia, circulation, and establishment of a metastatic focus. In reality, several of these processes overlap and occur even simultaneously, but such a presentation would be unreadable. Metastasis requires cell migration toward higher oxygen tension, which is based on changing the structure of the cell (epithelial-mesenchymal transition), orientation within the stroma and stroma interaction, and communication with the immune system to avoid attack. Once in the blood stream, cells have to survive trapping by the coagulation system, to survive shear stress in small blood vessels, and to find the right location for extravasation. Once outside in the metastatic locus, tumor cells have to learn the communication with the “foreign” stroma cells to establish vascular supply and again express molecules, which induce immune tolerance.

[1]  S. Courtneidge,et al.  The 'ins' and 'outs' of podosomes and invadopodia: characteristics, formation and function , 2011, Nature Reviews Molecular Cell Biology.

[2]  A. Silvani,et al.  CXCL12, CXCR4 and CXCR7 expression in brain metastases , 2009, Cancer biology & therapy.

[3]  M. Selman,et al.  Expression of matrix metalloproteases by fibrocytes: possible role in migration and homing. , 2010, American journal of respiratory and critical care medicine.

[4]  Sung-Hoon Kim,et al.  Inhibition of ZNF746 suppresses invasion and epithelial to mesenchymal transition in H460 non-small cell lung cancer cells. , 2014, Oncology reports.

[5]  F. Lecanda,et al.  PDGFR signaling blockade in marrow stroma impairs lung cancer bone metastasis. , 2011, Cancer research.

[6]  Dong-Yeop Shin,et al.  EGFR Mutation and Brain Metastasis in Pulmonary Adenocarcinomas , 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[7]  R. Franco,et al.  Inhibition of stromal CXCR4 impairs development of lung metastases , 2012, Cancer Immunology, Immunotherapy.

[8]  N. Probst-Hensch,et al.  Prognostic Significance of Epithelial-Mesenchymal and Mesenchymal-Epithelial Transition Protein Expression in Non–Small Cell Lung Cancer , 2008, Clinical Cancer Research.

[9]  V. Seshan,et al.  Next-Generation Sequencing of Stage IV Squamous Cell Lung Cancers Reveals an Association of PI3K Aberrations and Evidence of Clonal Heterogeneity in Patients with Brain Metastases. , 2015, Cancer discovery.

[10]  F. Klamt,et al.  The prognostic impact of tumor-associated macrophages and intra-tumoral apoptosis in non-small cell lung cancer. , 2014, Histology and histopathology.

[11]  Jing Wu,et al.  In vivo RNAi screen identifies candidate signaling genes required for collective cell migration in Drosophila ovary , 2014, Science China Life Sciences.

[12]  S. Ramaswamy,et al.  Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis , 2004, Cell.

[13]  M. Wang,et al.  The Function of SARI in Modulating Epithelial-Mesenchymal Transition and Lung Adenocarcinoma Metastasis , 2012, PloS one.

[14]  R. Jain,et al.  Endothelial focal adhesion kinase mediates cancer cell homing to discrete regions of the lungs via E-selectin up-regulation , 2011, Proceedings of the National Academy of Sciences.

[15]  W. Dougall,et al.  RANKL Inhibition Blocks Osteolytic Lesions and Reduces Skeletal Tumor Burden in Models of Non–Small-Cell Lung Cancer Bone Metastases , 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[16]  Liu Li,et al.  The prevalence of FOXP3+ regulatory T-cells in peripheral blood of patients with NSCLC. , 2009, Cancer biotherapy & radiopharmaceuticals.

[17]  Nuclear LEF1/TCF4 correlate with poor prognosis but not with nuclear β-catenin in cerebral metastasis of lung adenocarcinomas , 2012, Clinical & Experimental Metastasis.

[18]  D. Harder,et al.  Astrocytes Directly Influence Tumor Cell Invasion and Metastasis In Vivo , 2013, PloS one.

[19]  Wei Li,et al.  Effect of hypoxia-inducible factor-1α on transcription of survivin in non-small cell lung cancer , 2009, Journal of experimental & clinical cancer research : CR.

[20]  Xuetao Cao,et al.  Tumor-Educated CD11bhighIalow Regulatory Dendritic Cells Suppress T Cell Response through Arginase I1 , 2009, The Journal of Immunology.

[21]  H. Sakurai,et al.  RANKL-induced CCL22/macrophage-derived chemokine produced from osteoclasts potentially promotes the bone metastasis of lung cancer expressing its receptor CCR4 , 2006, Clinical & Experimental Metastasis.

[22]  Y. Miller,et al.  Overexpression of vascular endothelial growth factor and its receptors in bronchial dypslasia demonstrated by quantitative RT-PCR analysis. , 2005, Lung cancer.

[23]  A. Gemma,et al.  Nestin regulates proliferation, migration, invasion and stemness of lung adenocarcinoma. , 2014, International journal of oncology.

[24]  B. Zhivotovsky,et al.  Suppression of basal autophagy reduces lung cancer cell proliferation and enhances caspase-dependent and -independent apoptosis by stimulating ROS formation , 2012, Autophagy.

[25]  C. Degott,et al.  Angiogenesis and extracellular matrix remodelling in bronchioloalveolar carcinomas: distinctive patterns in mucinous and non‐mucinous tumours , 2004, Histopathology.

[26]  C. Horak,et al.  Metastasis gets site specific. , 2005, Cancer cell.

[27]  Gaetano Rocco,et al.  Epithelial to Mesenchymal Transition by TGFβ-1 Induction Increases Stemness Characteristics in Primary Non Small Cell Lung Cancer Cell Line , 2011, PloS one.

[28]  M. Kris,et al.  Serpins Promote Cancer Cell Survival and Vascular Co-Option in Brain Metastasis , 2014, Cell.

[29]  Xingbin Hu,et al.  Notch signaling determines the M1 versus M2 polarization of macrophages in antitumor immune responses. , 2010, Cancer Research.

[30]  Ruth J. Muschel,et al.  Coagulation Facilitates Tumor Cell Spreading in the Pulmonary Vasculature during Early Metastatic Colony Formation , 2004, Cancer Research.

[31]  J. Becker,et al.  A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth , 2002, Nature Network Boston.

[32]  Na Li,et al.  SOX2 Gene Regulates the Transcriptional Network of Oncogenes and Affects Tumorigenesis of Human Lung Cancer Cells , 2012, PloS one.

[33]  Changli Wang,et al.  MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN. , 2012, Biochimica et biophysica acta.

[34]  Z. Liao,et al.  SNPs in the TGF-β Signaling Pathway Are Associated with Increased Risk of Brain Metastasis in Patients with Non–Small-Cell Lung Cancer , 2012, PloS one.

[35]  W. Xu,et al.  Depletion of CD4+CD25high regulatory T cells from tumor infiltrating lymphocytes predominantly induces Th1 type immune response in vivo which inhibits tumor growth in adoptive immunotherapy , 2009, Cancer biology & therapy.

[36]  F. Dehghani,et al.  Coculture System with an Organotypic Brain Slice and 3D Spheroid of Carcinoma Cells , 2013, Journal of visualized experiments : JoVE.

[37]  David Haussler,et al.  Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma , 2011, Proceedings of the National Academy of Sciences.

[38]  H. Kijima,et al.  Mesenchymal Stromal Cells Promote Tumor Growth through the Enhancement of Neovascularization , 2011, Molecular medicine.

[39]  B. Housset,et al.  Expression and regulation of vascular endothelial growth factor in human pulmonary epithelial cells. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[40]  A. J. Clifford,et al.  BIOCHIMICA ET BIOPHYSICA ACTA , 2022 .

[41]  Oliver T. Bruns,et al.  Selectins Mediate Small Cell Lung Cancer Systemic Metastasis , 2014, PloS one.

[42]  D. Nguyen,et al.  EGF receptor activates MET through MAPK to enhance non-small cell lung carcinoma invasion and brain metastasis. , 2013, Cancer research.

[43]  P. Laurent-Puig,et al.  TWIST1 a New Determinant of Epithelial to Mesenchymal Transition in EGFR Mutated Lung Adenocarcinoma , 2012, PloS one.

[44]  A. Friedl,et al.  Colorectal cancer desmoplastic reaction up-regulates collagen synthesis and restricts cancer cell invasion , 2011, Cell and Tissue Research.

[45]  Y. Sher,et al.  ADAM9 Up-Regulates N-Cadherin via miR-218 Suppression in Lung Adenocarcinoma Cells , 2014, PloS one.

[46]  Javier De Las Rivas,et al.  A novel lung cancer signature mediates metastatic bone colonization by a dual mechanism. , 2008, Cancer research.

[47]  G. Prendergast,et al.  IDO is a nodal pathogenic driver of lung cancer and metastasis development. , 2012, Cancer discovery.

[48]  I. Wistuba,et al.  RHOB influences lung adenocarcinoma metastasis and resistance in a host‐sensitive manner , 2014, Molecular oncology.

[49]  E. Yamamoto,et al.  Significance of stromal desmoplasia and myofibroblast appearance at the invasive front in squamous cell carcinoma of the oral cavity , 2009, Head & neck.

[50]  Xianghuo He,et al.  Quantitative proteomic analysis identifies CPNE3 as a novel metastasis-promoting gene in NSCLC. , 2013, Journal of proteome research.

[51]  Lin Han,et al.  SIRT1 is highly expressed in brain metastasis tissues of non-small cell lung cancer (NSCLC) and in positive regulation of NSCLC cell migration. , 2013, International journal of clinical and experimental pathology.

[52]  S. Israels,et al.  BNIP3 plays a role in hypoxic cell death in human epithelial cells that is inhibited by growth factors EGF and IGF , 2003, Oncogene.

[53]  Wim Timens,et al.  Genomic aberrations in squamous cell lung carcinoma related to lymph node or distant metastasis. , 2009, Lung cancer.

[54]  W. Fu,et al.  Involvement of matrix metalloproteinase-9 in stromal cell-derived factor-1/CXCR4 pathway of lung cancer metastasis. , 2008, Carcinogenesis.

[55]  H. Popper,et al.  Sarcomatoid carcinomas of the lung—are these histogenetically heterogeneous tumors? , 2006, Virchows Archiv.

[56]  T. Lyberg,et al.  Immunohistochemical localization of coagulation, fibrinolytic and antifibrinolytic markers in adenocarcinoma of the lung , 1991, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[57]  Michael Thomas,et al.  MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer , 2003, Oncogene.

[58]  Jun-ling Liu,et al.  Activation of notch‐1 enhances epithelial–mesenchymal transition in gefitinib‐acquired resistant lung cancer cells , 2012, Journal of cellular biochemistry.

[59]  F. Wang,et al.  -216G/T (rs712829), a functional variant of the EGFR promoter, is associated with the pleural metastasis of lung adenocarcinoma , 2013, Oncology letters.

[60]  Zuozhang Yang,et al.  Genome-Wide Identification of Bone Metastasis-Related MicroRNAs in Lung Adenocarcinoma by High-Throughput Sequencing , 2013, PloS one.

[61]  D. Slamon,et al.  RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis. , 2010, Lung cancer.

[62]  S. Grossman,et al.  The alternative reading frame tumor suppressor antagonizes hypoxia-induced cancer cell migration via interaction with the COOH-terminal binding protein corepressor. , 2007, Cancer research.

[63]  A. Whetton,et al.  The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets. , 2014, Cancer treatment reviews.

[64]  H. Aburatani,et al.  Primary tumours modulate innate immune signalling to create pre-metastatic vascular hyperpermeability foci , 2013, Nature Communications.

[65]  H. Popper Lung adenocarcinomas: comparison between mice and men. , 2015, Methods in molecular biology.

[66]  W. Guo,et al.  Differential Expression of the RANKL/RANK/OPG System Is Associated with Bone Metastasis in Human Non-Small Cell Lung Cancer , 2013, PloS one.

[67]  K. Luzzi,et al.  Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. , 1998, The American journal of pathology.

[68]  A. Varki,et al.  Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas. , 2003, The Journal of clinical investigation.

[69]  R. Mirimanoff,et al.  CYR61 and alphaVbeta5 integrin cooperate to promote invasion and metastasis of tumors growing in preirradiated stroma. , 2008, Cancer research.

[70]  E. Wang,et al.  Hypoxia-induced CCR7 expression via HIF-1α and HIF-2α correlates with migration and invasion in lung cancer cells , 2009, Cancer biology & therapy.

[71]  Tae Min Kim,et al.  Heterogeneity of Genetic Changes Associated with Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancer , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[72]  I. Takanami,et al.  Expression of Ets-1 Is Correlated with Urokinase-Type Plasminogen Activator and Poor Prognosis in Pulmonary Adenocarcinoma , 2001, Tumor Biology.

[73]  E. Brambilla,et al.  Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF‐R1‐Flt1 and VEGF‐R2‐Flk1/KDR) in non‐small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival , 1999, The Journal of pathology.

[74]  W. Dougall,et al.  Mixed Metastatic Lung Cancer Lesions in Bone Are Inhibited by Noggin Overexpression and Rank:Fc Administration , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[75]  N. Pećina-Šlaus,et al.  Brain Metastases from Lung Cancer Show Increased Expression of DVL1, DVL3 and Beta-Catenin and Down-Regulation of E-Cadherin , 2014, International journal of molecular sciences.

[76]  B. Ylstra,et al.  Genomic Profiles Associated with Early Micrometastasis in Lung Cancer: Relevance of 4q Deletion , 2009, Clinical Cancer Research.

[77]  J. Hung,et al.  MicroRNA-33a functions as a bone metastasis suppressor in lung cancer by targeting parathyroid hormone related protein. , 2013, Biochimica et biophysica acta.

[78]  W. Berger,et al.  High rate of FGFR1 amplifications in brain metastases of squamous and non-squamous lung cancer. , 2014, Lung cancer.

[79]  M. Hung,et al.  ADAM9 promotes lung cancer metastases to brain by a plasminogen activator-based pathway. , 2014, Cancer research.

[80]  Ming Chen,et al.  TGF-beta induces fibroblast activation protein expression; fibroblast activation protein expression increases the proliferation, adhesion, and migration of HO-8910PM [corrected]. , 2009, Experimental and molecular pathology.

[81]  E Helene Sage,et al.  Enhanced expression of SPARC/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patients. , 2003, Cancer research.

[82]  Leo Kinarsky,et al.  Identification of functional cell adhesion molecules with a potential role in metastasis by a combination of in vivo phage display and in silico analysis. , 2007, Omics : a journal of integrative biology.

[83]  Myung-Soo Kang,et al.  Alpha-Smooth Muscle Actin (ACTA2) Is Required for Metastatic Potential of Human Lung Adenocarcinoma , 2013, Clinical Cancer Research.

[84]  I. Pass,et al.  A role for the podosome/invadopodia scaffold protein Tks5 in tumor growth in vivo. , 2008, European journal of cell biology.

[85]  J. Tímár,et al.  Protein expression differences between lung adenocarcinoma and squamous cell carcinoma with brain metastasis. , 2014, Anticancer research.

[86]  D. Spector,et al.  The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. , 2013, Cancer research.

[87]  R. Xiang,et al.  Oral DNA vaccines target the tumor vasculature and microenvironment and suppress tumor growth and metastasis , 2008, Immunological reviews.

[88]  C. Rudin,et al.  Notch Signaling Contributes to Lung Cancer Clonogenic Capacity In Vitro but May Be Circumvented in Tumorigenesis In Vivo , 2011, Molecular Cancer Research.

[89]  M. Meyerson,et al.  SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer , 2011, Modern Pathology.

[90]  Mingyong Han,et al.  Systemic inflammation promotes lung metastasis via E-selectin upregulation in mouse breast cancer model , 2014, Cancer biology & therapy.

[91]  Fu-Tsai Chung,et al.  CD14(+)S100A9(+) monocytic myeloid-derived suppressor cells and their clinical relevance in non-small cell lung cancer. , 2012, American journal of respiratory and critical care medicine.

[92]  R. Muschel,et al.  VCAM-1 and VAP-1 recruit myeloid cells that promote pulmonary metastasis in mice. , 2013, Blood.

[93]  G. Pelosi,et al.  Alterations of the Notch pathway in lung cancer , 2009, Proceedings of the National Academy of Sciences.

[94]  Z. Liao,et al.  Associations between Single-Nucleotide Polymorphisms in the PI3K–PTEN–AKT–mTOR Pathway and Increased Risk of Brain Metastasis in Patients with Non–Small Cell Lung Cancer , 2013, Clinical Cancer Research.

[95]  S. Mader,et al.  Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis , 2000, Oncogene.

[96]  M. Noguchi,et al.  The development and progression of adenocarcinoma of the lung. , 1995, Cancer treatment and research.

[97]  C. Panje,et al.  Prognostic significance of histology after resection of brain metastases and whole brain radiotherapy in non-small cell lung cancer (NSCLC) , 2015, Clinical & Experimental Metastasis.

[98]  E. Smit,et al.  EGFR mutated non-small cell lung cancer patients: more prone to development of bone and brain metastases? , 2014, Lung cancer.

[99]  A. Bertuzzi,et al.  Cell kinetics in a tumour cord. , 2000, Journal of theoretical biology.

[100]  P. Sykacek,et al.  A dual role for autophagy in a murine model of lung cancer , 2014, Nature Communications.

[101]  J. Snyder,et al.  Development of a Unique Small Molecule Modulator of CXCR4 , 2012, PloS one.

[102]  B. Gao,et al.  Regulation of the chemokine receptor CXCR4 and metastasis by hypoxia-inducible factor in non small cell lung cancer cell lines , 2006, Cancer biology & therapy.

[103]  H. Popper,et al.  Invasion of blood vessels as significant prognostic factor in radically resected T1-3N0M0 non-small-cell lung cancer. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[104]  Chung-Wu Lin,et al.  CHC promotes tumor growth and angiogenesis through regulation of HIF-1α and VEGF signaling. , 2012, Cancer letters.

[105]  M. Noguchi,et al.  Phenotypic differences of proliferating fibroblasts in the stroma of lung adenocarcinoma and normal bronchus tissue , 2004, Cancer science.

[106]  Lei Zhao,et al.  Recruitment of monocytes/macrophages by tissue factor-mediated coagulation is essential for metastatic cell survival and premetastatic niche establishment in mice. , 2012, Blood.

[107]  F. Lecanda,et al.  Inhibition of Collagen Receptor Discoidin Domain Receptor-1 (DDR1) Reduces Cell Survival, Homing, and Colonization in Lung Cancer Bone Metastasis , 2012, Clinical Cancer Research.

[108]  M. Cao,et al.  IL-17E, a proinflammatory cytokine, has antitumor efficacy against several tumor types in vivo , 2010, Cancer Immunology, Immunotherapy.

[109]  E. Puré,et al.  Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice. , 2009, The Journal of clinical investigation.

[110]  K. Alitalo,et al.  Effects of Angiopoietin-2-Blocking Antibody on Endothelial Cell–Cell Junctions and Lung Metastasis , 2012, Journal of the National Cancer Institute.

[111]  S. Liang,et al.  Notch-1 stimulates survival of lung adenocarcinoma cells during hypoxia by activating the IGF-1R pathway , 2010, Oncogene.

[112]  J. Wan,et al.  The effects of HIF-1alpha on gene expression profiles of NCI-H446 human small cell lung cancer cells , 2009, Journal of experimental & clinical cancer research : CR.

[113]  H. Satoh,et al.  Specific organ metastases and survival in metastatic non-small-cell lung cancer. , 2015, Molecular and clinical oncology.

[114]  Zhou Wang,et al.  High-level C-X-C chemokine receptor type 4 expression correlates with brain-specific metastasis following complete resection of non-small cell lung cancer , 2014, Oncology letters.

[115]  B. Son,et al.  E-cadherin as a predictive marker of brain metastasis in non-small-cell lung cancer, and its regulation by pioglitazone in a preclinical model , 2012, Journal of Neuro-Oncology.

[116]  S. Hoersch,et al.  Differential Tks5 isoform expression contributes to metastatic invasion of lung adenocarcinoma. , 2013, Genes & development.

[117]  W. Sessa,et al.  Caveolin-1-deficient mice have increased tumor microvascular permeability, angiogenesis, and growth. , 2007, Cancer research.

[118]  Yan Xu,et al.  The Ubiquitin–CXCR4 Axis Plays an Important Role in Acute Lung Infection–Enhanced Lung Tumor Metastasis , 2013, Clinical Cancer Research.

[119]  Herb Chen,et al.  Tumor suppressor role of Notch-1 signaling in neuroendocrine tumors. , 2007, The oncologist.

[120]  I. Holen,et al.  Targeting RANKL in metastasis , 2014, BoneKEy reports.

[121]  J. Siegfried,et al.  Lung cancer-derived bombesin-like peptides down-regulate the generation and function of human dendritic cells , 2003, Journal of Neuroimmunology.

[122]  I. Bechmann,et al.  Microglia promote colonization of brain tissue by breast cancer cells in a Wnt‐dependent way , 2010, Glia.

[123]  Ling Wei,et al.  Lysyl oxidase may play a critical role in hypoxia-induced NSCLC cells invasion and migration. , 2012, Cancer biotherapy & radiopharmaceuticals.

[124]  K. Willecke,et al.  Connexin-43 upregulation in micrometastases and tumor vasculature and its role in tumor cell attachment to pulmonary endothelium. , 2008, BMC medicine.

[125]  David E. Misek,et al.  Genomic and proteomic analyses of vascular endothelial growth factor and insulin-like growth factor-binding protein 3 in lung adenocarcinomas. , 2004, Clinical lung cancer.

[126]  E. Puré,et al.  Notch1 is required for Kras-induced lung adenocarcinoma and controls tumor cell survival via p53. , 2013, Cancer research.

[127]  S. Eccles,et al.  Phosphoinositide 3-Kinase Signalling Pathways in Tumor Progression, Invasion and Angiogenesis , 2004, Tumori.